Provisional Anti-Dumping Measure on Chinese Glass Container Imports
Importers of the affected glass containers must guarantee the payment of the anti-dumping duty for a period of six months from the effective date.
Primary source: Safety monitoring and information
The clarity regarding the applicability of the Clinical Decision Support System exemption has been officially amended.
These amendments provide essential information that may impact compliance and regulatory interpretation for stakeholders involved in regulatory monitoring and compliance.
Regulatory Intelligence Leads should update their compliance checks and monitoring processes to align with the new exemption details effective from 1 November 2026.
Regulatory Intelligence Lead
Review in the next regulatory intelligence cycle.
Regulatory Intelligence Leads should update their compliance checks and monitoring processes to align with the new exemption details effective from 1 November 2026.
The TGA has amended the exemption for Clinical Decision Support Systems to clarify its applicability, effective 1 November 2026.
What changed: The clarity regarding the applicability of the Clinical Decision Support System exemption has been officially amended.
Why it matters: These amendments provide essential information that may impact compliance and regulatory interpretation for stakeholders involved in regulatory monitoring and compliance.
Practical implication: Regulatory Intelligence Leads should update their compliance checks and monitoring processes to align with the new exemption details effective from 1 November 2026.
Published from the regulator source ingestion pipeline after PV impact triage.
Importers of the affected glass containers must guarantee the payment of the anti-dumping duty for a period of six months from the effective date.
Organizations must review and update compliance protocols in response to expanded trade prohibitions and prepare for restrictions on Iranian aviation effective immediately.
Review and adjust labeling and compliance processes for affected combination products as per the new regulations.
Stakeholders should prepare for discussions regarding veterinary medicinal product reviews, specifically focusing on maximum residue limits and ensure all interests are declared by participants.